▟ Vinebot intrinsic value, daily

← back

LH Labcorp

healthcare · valued with glm-5.2 medium conviction · deep-dived 2026-09-15

HOLD
Intrinsic value$109.87
Price (at call)$315.31
Margin of safety -65.2%
vs market (rating basis) -19.2%

Model unavailable; showing baseline valuation.

⚠ LLM error: empty response; using baseline

The story

Value drivers

Revenue growth (Y1)5.6%
Terminal growth3.5%
Forecast horizon10y
Target operating margin10.2%
Years to target margin5
Sales-to-capital1.01
Beta0.85
Failure probability0.0%
Cost of capital (WACC)8.3%
Terminal WACC8.8%

Valuation bridge

PV of explicit FCFF4.50B
PV of terminal value9.50B
Equity value8.91B
÷ shares → per share$109.87

News

bearish -0.20 · 8 articles

  • Labcorp Bets Big on AI, Specialty Testing to Drive Growth Through 2029
  • 1 Mid-Cap Stock with Competitive Advantages and 2 That Underwhelm
  • 1 Profitable Stock Worth Your Attention and 2 Facing Headwinds
  • New Study Reveals Strongest State Economies, Only 1 State Was Better Than Texas
  • Market Shocks Are Not Where Hims & Hers Health Stock Has Fallen Furthest
  • Labcorp Holdings (LH) Unveiled The First FDA Cleared Single Biomarker Alzheimer’s Blood Test
  • Are Wall Street Analysts Bullish on Labcorp Holdings Stock?
  • 3 Reasons LH is Risky and 1 Stock to Buy Instead

Projected free cash flow to the firm

YrRevenueGrowthMarginNOPATReinvestFCFFPV
1 15.14B 5.6% 10.2% 1.22B 788.64M 433.41M 400.20M
2 15.95B 5.3% 10.2% 1.29B 798.24M 488.88M 416.83M
3 16.76B 5.1% 10.2% 1.35B 804.73M 547.97M 431.41M
4 17.58B 4.9% 10.2% 1.42B 807.90M 610.65M 443.92M
5 18.40B 4.6% 10.2% 1.48B 807.55M 676.83M 454.33M
6 19.21B 4.4% 10.2% 1.55B 803.50M 746.37M 462.62M
7 20.01B 4.2% 10.2% 1.61B 795.59M 819.12M 468.81M
8 20.80B 4.0% 10.2% 1.68B 783.71M 894.88M 472.92M
9 21.58B 3.7% 10.2% 1.74B 767.76M 973.41M 475.01M
10 22.33B 3.5% 10.2% 1.80B 747.67M 1.05B 475.12M

History

DatePriceIntrinsicMoSRating
2026-09-15$315.31 $109.87 -65.2% HOLD
2026-07-27$296.77 $135.59 -54.3% HOLD
2026-06-23$258.59 $166.44 -35.6% BUY